Veracyte, Inc. (VCYT) stock analysis and AI prediction
The company facts of Veracyte, Inc., with its price and AI prediction for the next 10 market days in SharePreds.
Keep looking in SharePreds
You have looked at today's stocks on this website. SharePreds shows every stock's likelihood of rising, its chart and how its earlier predictions ended, with alerts on the ones you follow.
See all five apps
About Veracyte, Inc.
Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder).
- Sector
- Healthcare
- Exchange
- NASDAQ
- Market value
- $2.0 billion
- Size
- Mid cap
- Employees
- 755
- Headquarters
- SOUTH SAN FRANCISCO, CA
- Listed since
- Oct. 30, 2013
- Website
- veracyte.com
More Healthcare stocks
Other mid cap stocks
Keep going
VCYT questions
What is the AI prediction for VCYT stock?
Each market day our model rates Veracyte, Inc. (VCYT) Bullish, Neutral or Bearish for the next 10 market days. Predictions are indicative: they rest on price and volume data, and they can be wrong.
How often is the VCYT prediction updated?
Each market day, Monday to Friday, except market holidays. The date of the prediction is shown beside it.
What do Bullish, Neutral and Bearish mean?
Bullish means the model sees a rise as likely over the next 10 market days, Bearish a fall, and Neutral no clear direction.
Where can I see the exact likelihood for VCYT?
In the SharePreds app for iPhone and Android, with the stock's chart, alerts on it and how its earlier predictions ended.
Where can I see VCYT options?
The VCYT options page explains its calls, puts and Greeks. The full VCYT options chain, every strike and expiry, is in the OpPreds app.